Raymond James Financial’s ORIX IX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
271,060
+61,508
+29% +$2.19M ﹤0.01% 2131
2026
Q1
$6.28M Buy
209,552
+191,391
+1,054% +$6.07M ﹤0.01% 2412
2025
Q4
$531K Sell
18,161
-425
-2% -$11.3K ﹤0.01% 4233
2025
Q3
$485K Buy
18,586
+1,429
+8% +$35.4K ﹤0.01% 4132
2025
Q2
$386K Buy
17,157
+457
+3% +$9.38K ﹤0.01% 4151
2025
Q1
$349K Buy
16,700
+1,995
+14% +$41.8K ﹤0.01% 4127
2024
Q4
$312K Buy
+14,705
New +$322K ﹤0.01% 4161

Other funds holding IX

Raymond James Financial's IX Position: Q2 2026 in Review

Raymond James Financial increased its ORIX (IX) stake by 29% in Q2 2026, buying an estimated $2.19M and bringing the position to 271,060 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Raymond James Financial first reported a position in IX in Q4 2024 and has held it in 7 quarters since. 319 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Raymond James Financial held 271,060 shares of ORIX worth $10.3M as of Q2 2026.
  • Raymond James Financial bought 61,508 ORIX shares in Q2 2026, an estimated $2.19M.
  • ORIX made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2131 holding.
  • Raymond James Financial first reported a position in ORIX in Q4 2024 and has held it in 7 quarters since.
  • 319 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.